Phase II study of chemoembolization with drug-eluting beads in patients with hepatic neuroendocrine metastases: High incidence of biliary injury

CardioVascular and Interventional Radiology

Volumn 36, Issue 2, 2013, Pages 449-459

  Bhagat, Nikhil ^a   Reyes, Diane K ^a   Lin, Mingde ^b   Kamel, Ihab ^a   Pawlik, Timothy M ^c   Frangakis, Constantine ^d   Geschwind, J F ^a  

^a JOHNS HOPKINS HOSPITAL   (United States)

^b PHILIPS RESEARCH LABORATORIES   (Netherlands)

^c JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

Biliary injury; Chemoembolization; Drug eluting beads; Neuroendocrine metastases

Indexed keywords

ANTINEOPLASTIC AGENT; DOXORUBICIN; IOXILAN; OCTREOTIDE;

ABDOMINAL PAIN; ADULT; AGED; ALOPECIA; ANEMIA; ANOREXIA; ASCITES; BILE DUCT INJURY; BILOMA; CARDIOVASCULAR EQUIPMENT; CHEMOEMBOLIZATION; CLINICAL ARTICLE; CONSTIPATION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEVICE SAFETY; DIARRHEA; DRUG DELIVERY SYSTEM; DRUG ELUTING BEAD; DRUG FEVER; DRUG RESPONSE; DRUG SAFETY; DRY SKIN; DYSPNEA; EDEMA; EXTERNAL BEAM RADIOTHERAPY; FATIGUE; FEMALE; HEMATOMA; HUMAN; HYPERBILIRUBINEMIA; HYPERGLYCEMIA; HYPOALBUMINEMIA; HYPONATREMIA; HYPOTENSION; INCIDENCE; INTERNATIONAL NORMALIZED RATIO; LIVER ABSCESS; LIVER DYSFUNCTION; LIVER METASTASIS; LYMPHOCYTOPENIA; MALE; NAUSEA; NEUROENDOCRINE TUMOR; NEUROPATHY; NIGHT SWEAT; PAIN; PERCUTANEOUS DRAINAGE; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; REVIEW; SIDE EFFECT; TASTE DISORDER; TREATMENT RESPONSE; TUMOR VOLUME; UPPER ABDOMINAL PAIN;

AGED; ANTIBIOTICS, ANTINEOPLASTIC; BILIARY TRACT; CHEMOEMBOLIZATION, THERAPEUTIC; CONTRAST MEDIA; DOXORUBICIN; FEMALE; HUMANS; INCIDENCE; LIVER NEOPLASMS; MAGNETIC RESONANCE IMAGING; MALE; MICROSPHERES; NEUROENDOCRINE TUMORS; PATIENT SELECTION; TREATMENT OUTCOME; TUMOR BURDEN;

EID: 84875223168     PISSN: 01741551     EISSN: 1432086X     Source Type: Journal    
DOI: 10.1007/s00270-012-0424-y     Document Type: Review

References (41)

1. Modlin IM, Lye KD, Kidd M (2003) A 5-decade analysis of 13,715 carcinoid tumors. Cancer 97(4):934-959
2. Kress O, Wagner HJ, Wied M, Klose KJ, Arnold R, Alfke H (2003) Transarterial chemoembolization of advanced liver metastases of neuroendocrine tumors - A retrospective single-center analysis. Digestion 68(2-3):94-101
3. Moertel CG (1983) Treatment of the carcinoid tumor and the malignant carcinoid syndrome. J Clin Oncol 1(11):727-740
4. Saltz L et al (1994) A phase II trial of alpha-interferon and 5-fluorouracil in patients with advanced carcinoid and islet cell tumors. Cancer 74(3):958-961
5. Schnirer I, Yao JC, Ajani JA (2003) Carcinoid - a comprehensive review. Acta Oncol 42(7):672-692
6. Mayo SC, de Jong MC, Pawlik TM (2011) Surgical management and emerging therapies to prolong survival in metastatic neuroendocrine cancer. Ann Surg Oncol 18(53):S220-221
7. Gupta S et al (2005) Hepatic arterial embolization and chemoembolization for the treatment of patients with metastatic neuroendocrine tumors: variables affecting response rates and survival. Cancer 104(8):1590-1602
8. Touzios JG et al (2005) Neuroendocrine hepatic metastases: does aggressive management improve survival? Ann Surg 241(5):776-783 discussion 783-785
9. Ruutiainen AT et al (2007) Chemoembolization and bland embolization of neuroendocrine tumor metastases to the liver. J Vasc Interv Radiol 18(7):847-855
10. Vogl TJ et al (2009) Liver metastases of neuroendocrine tumors: treatment with hepatic transarterial chemotherapy using two therapeutic protocols. AJR Am J Roentgenol 193(4):941-947
11. Mayo SC et al (2011) Surgery versus intra-arterial therapy for neuroendocrine liver metastasis: a multicenter international analysis. Ann Surg Oncol 18(13):3657-3665
12. de Baere T et al (2008) Transarterial chemoembolization of liver metastases from well differentiated gastroenteropancreatic endocrine tumors with doxorubicin-eluting beads: preliminary results. J Vasc Interv Radiol 19(6):855-861
13. Gaur SK et al (2011) Hepatic arterial chemoembolization using drug-eluting beads in gastrointestinal neuroendocrine tumor metastatic to the liver. Cardiovasc Intervent Radiol 34(3):566-572
14. El-Serag HB et al (2003) The continuing increase in the incidence of hepatocellular carcinoma in the United States: an update. Ann Intern Med 139(10):817-823
15. Davila JA et al (2004) Hepatitis C infection and the increasing incidence of hepatocellular carcinoma: a population-based study. Gastroenterology 127(5):1372-1380
16. Parkin DM et al (2005) Global cancer statistics, 2002. CA Cancer J Clin 55(2):74-108
17. Bosch FX et al (2005) Epidemiology of hepatocellular carcinoma. Clin Liver Dis 9(2):191-211 v
18. Srivatanakul P, Sriplung H, Deerasamee S (2004) Epidemiology of liver cancer: an overview. Asian Pac J Cancer Prev 5(2):118-125
19. Ahmed F et al (2008) National trends and disparities in the incidence of hepatocellular carcinoma, 1998-2003. Prev Chronic Dis 5(3):A74
20. Jemal A et al (2008) Cancer statistics, 2008. CA Cancer J Clin 58(2):71-96
21. Reuter NP et al (2009) Radiofrequency ablation vs. resection for hepatic colorectal metastasis: therapeutically equivalent? J Gastrointest Surg 13(3):486-491
22. Reyes DK et al (2009) Single-center phase II trial of transarterial chemoembolization with drug-eluting beads for patients with unresectable hepatocellular carcinoma: initial experience in the United States. Cancer J 15(6):526-532
23. Therasse P et al (2000) New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada. J Natl Cancer Inst 92(3):205-216
24. Bruix J, Sherman M (2005) Management of hepatocellular carcinoma. Hepatology 42(5):1208-1236
25. Kamel IR et al (2009) Unresectable hepatocellular carcinoma: serial early vascular and cellular changes after transarterial chemoembolization as detected with MR imaging. Radiology 250(2):466-473
26. Gasnier A et al. (2010) In: IEEE international symposium on biomedical imaging: from nano to macro, Austin, TX, USA, 13-18 June 2010
27. Mory B et al. (2009) Non-Euclidean image-adaptive radial basis functions for 3D interactive segmentation. In: Twelfth IEEE international conference on computer vision (ICCV), Kyoto, Japan
28. Miyayama S et al (2010) Main bile duct stricture occurring after transcatheter arterial chemoembolization for hepatocellular carcinoma. Cardiovasc Intervent Radiol 33(6):1168-1179
29. Kim HK et al (2001) Ischemic bile duct injury as a serious complication after transarterial chemoembolization in patients with hepatocellular carcinoma. J Clin Gastroenterol 32(5):423-427
30. Sakamoto I et al (2003) Intrahepatic biloma formation (bile duct necrosis) after transcatheter arterial chemoembolization. AJR Am J Roentgenol 181(1):79-87
31. Yu JS et al (2002) Predisposing factors of bile duct injury after transcatheter arterial chemoembolization (TACE) for hepatic malignancy. Cardiovasc Intervent Radiol 25(4):270-274
32. Liapi E, Geschwind JF (2007) Transcatheter and ablative therapeutic approaches for solid malignancies. J Clin Oncol 25(8):978-986
33. Liapi E, Geschwind JF (2010) Intra-arterial therapies for hepatocellular carcinoma: where do we stand? Ann Surg Oncol 17(5):1234-1246
34. Lammer J et al (2010) Prospective randomized study of doxorubicin-eluting-bead embolization in the treatment of hepatocellular carcinoma: results of the PRECISION V study. Cardiovasc Intervent Radiol 33(1):41-52
35. Malagari K et al (2008) Transarterial chemoembolization of unresectable hepatocellular carcinoma with drug eluting beads: results of an open-label study of 62 patients. Cardiovasc Intervent Radiol 31(2):269-280
36. Malagari K et al (2010) Prospective randomized comparison of chemoembolization with doxorubicin-eluting beads and bland embolization with BeadBlock for hepatocellular carcinoma. Cardiovasc Intervent Radiol 33(3):541-551
37. Varela M et al (2007) Chemoembolization of hepatocellular carcinoma with drug eluting beads: efficacy and doxorubicin pharmacokinetics. J Hepatol 46(3):474-481
38. Lencioni R et al. (2011) Transcatheter treatment of hepatocellular carcinoma with doxorubicin-loaded DC Bead (DEBDOX): technical recommendations. Cardiovasc Intervent Radiol, October 2011. [Epub ahead of print]
39. Geschwind JF et al (2002) Influence of a new prophylactic antibiotic therapy on the incidence of liver abscesses after chemoembolization treatment of liver tumors. J Vasc Interv Radiol 13(11):1163-1166
40. De Jong MC et al (2010) Liver-directed therapy for hepatic metastases in patients undergoing pancreaticoduodenectomy: a dual-center analysis. Ann Surg 252(1):142-148
41. Guiu B et al (2012) Liver/biliary injuries following chemoembolisation of endocrine tumours and hepatocellular carcinoma: lipiodol vs. drug-eluting beads. J Hepatol 56(3):609-617